Abstract. p12 CDK2-associating protein 1 (p12 CDK2-AP1 ) is a growth suppressor that negatively regulates cyclin-dependent kinase 2 (CDK2) activities. In addition, p12CDK2-AP1 has also been shown to interfere in DNA replication. A reduction of p12 CDK2-AP1 expression is known to be a negative prognostic indicator in patients with oral squamous cell carcinoma. To elucidate the role of p12 CDK2-AP1 expression in esophageal squamous cell carcinoma (ESCC), we immunohistochemically examined the expression of p12 CDK2-AP1 protein in 120 resected ESCC specimens and determined its association with the clinicopathological characteristics and prognosis. Of the 120 ESCCs, 79 (65.8%) showed positive staining (≥25% of cancer cells showing p12 CDK2-AP1 expression), while 41 (34.2%) lacked the staining (<25% of cancer cells showing p12 CDK2-AP1 expression). Negative staining for p12 CDK2-AP1 was found to be significantly associated with advanced lesions [depth of tumor (P=0.001), lymph node metastasis (P<0.001), pathological stage (P<0.0001) and venous invasion (P<0.0001)], and a poor prognosis (disease-free survival and overall survival: log-rank P<0.05). The rate of lymph node metastasis in patients with p12 CDK2-AP1 negative-T1 ESCC was significantly higher than that in patients with p12 CDK2-AP1 positive one (P<0.05). These results suggest the downregulation of p12 CDK2-AP1 to be related to tumor aggressiveness and a poor prognosis in patients with ESCC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.